EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth
Express Pharma
NOVEMBER 28, 2024
Key Findings: 75 per cent pharma leaders emphasise the need for sustainable manufacturing practices Highlight digital integration as crucial for improving healthcare access 63 per cent CXOs cite the need for a single global product standard 50 per cent believe regulatory simplification and streamlining will drive growth EY Parthenon (EY-P) in partnership with the Organisation of Pharmaceutical Producers of India (OPPI), released a report titled ‘Viksit Bharat@2047: Transforming India from pharma
Let's personalize your content